Page 15 - Activating Construct News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Zacks Investment Research Lowers Harpoon Therapeutics (NASDAQ:HARP) to Hold

Zacks Investment Research lowered shares of Harpoon Therapeutics (NASDAQ:HARP – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Friday, Zacks.com reports. According to Zacks, “Harpoon Therapeutics Inc. is a clinical-stage immunotherapy company developing a novel class of T cell engagers which harness the power of […]

United statesSan franciscoSchonfeld strategic advisorsHarpoon therapeutics incGoldman sachs group incZacks investment researchParametric portfolio associatesWells fargo companyHarpoon therapeutics company profile get ratingBarclays plcHarpoon therapeuticsGet ratingActivating constructSachs groupPortfolio associatesStrategic advisors

Harpoon Therapeutics Granted Orphan Drug Designation for HPN328 for Treatment of Small Cell Lung Cancer

SOUTH SAN FRANCISCO, Calif., March 07, 2022 Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company developing novel T cell engagers, today announced that the U.S. Food and. | March 7, 2022

United statesRoberth uhlJulie eastlandExchange commissionHarpoon therapeutics incDrug administrationOrphan drug designationDrug designationActivating constructHarpoon therapeuticsPrivate securities litigation reform actHarpoon therapeuticNc stock exchangePress releaseOod harp us41358p1066

Harpoon Therapeutics Presents Interim Clinical Data from its Ongoing Phase 1/2 Study and New Preclinical Results for BCMA-targeting TriTAC® HPN217 at the 63rd ASH Annual Meeting and Exposition

Harpoon Therapeutics Presents Interim Clinical Data from its Ongoing Phase 1/2 Study and New Preclinical Results for BCMA-targeting TriTAC® HPN217 at the 63rd ASH Annual Meeting and Exposition
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesRoberth uhlExchange commissionHarpoon therapeutics incAmerican society for hematologyInternational myeloma working groupHarpoon therapeuticsAmerican societyAnnual meetingActivating constructNatalie sacksChief medical officerDose escalationDose expansion studyPatients withCombination therapeutics

Harpoon Therapeutics to Present Preclinical Data on its TriTAC-XR Platform at the 36th Annual Meeting of the Society for Immunotherapy of Cancer

Harpoon Therapeutics to Present Preclinical Data on its TriTAC-XR Platform at the 36th Annual Meeting of the Society for Immunotherapy of Cancer
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesRoberth uhlKathryns kwantHarpoon therapeutics incHarpoon therapeuticsAnnual meetingNovel single agentPresentation dateActivating construct

Investegate |Arix Bioscience PLC Announcements | Arix Bioscience PLC: Harpoon presents updated interim clinical data for HPN424 at the 2021 ASCO Annual Meeting

Investegate announcements from Arix Bioscience PLC, Harpoon presents updated interim clinical data for HPN424 at the 2021 ASCO Annual Meeting

United statesCity ofUnited kingdomSupriya mathurCharlotte parryRoberth uhlShabnam bashirJerry mcmahonMary clarkArix bioscienceExchange commissionStrategic communicationsHarpoon therapeutics incAmerican society of clinical oncologyHarpoon therapeuticsClinical oncology